Extra Depression Care Helps Workers

Sept. 25, 2007 -- Depressed workers may feel better and accomplish more at work if they get a little extra help in addition to standard depression care.

That news appears in The Journal of the American Association.

Many employers may "experience a positive return on investment from outreach and enhanced treatment of depressed workers," write the researchers.

They included Philip Wang, MD, DrPH, of the National Institute of Mental Health.

Wang's team contacted thousands of employees at 16 large companies, including workers in the airline, insurance, banking, public utility, and manufacturing fields, as well as state government workers.

Interested employees completed surveys about their depression symptoms. Based on the results, the researchers focused on 604 depressed employees.

All of those depressed workers were eligible to get standard depression treatment. Roughly half also got a depression workbook and phone calls from trained counselors.

The counselors offered support and checked on the patients' progress, especially for depressed workers who refused to get in-person therapy.

Over the next year, the workers contacted by the phone counselors reported more improvement in their depression symptoms.

They also worked about two hours more per week than the other depressed workers and tended to keep their jobs.

Wang and colleagues call for further studies to see if the findings apply to other groups of workers, including people in blue-collar jobs

It is how much important to everyone?

In early September, "major newspapers reported the alarming news that suicides among young people were on the rise because of a precipitous drop in the use of antidepressants," writes Alison Bass. The academic study the news articles were based on concluded that new safety warnings for young people using antidepressant drugs had discouraged doctors from writing prescriptions for depressed youths. But there's a hole in that argument: "while there was indeed an upturn in suicide rates among youths ... the number of prescriptions for antidepressants in the same age group remained basically unchanged." Bass points out that the pharmaceutical companies that make antidepressants might "benefit from the latest alarm about an apparent upturn in youth suicide rates.
These companies have an enormous stake in reversing the current FDA warnings." Pfizer, which makes the antidepressant Zoloft and others, did provide $30,000 for the academic study, and the study's lead authors have ties to Pfizer, GlaxoSmithKline and Wyeth Pharmaceuticals. "This isn't the first time that suicide rates have been trotted out as a public relations weapon," Bass adds. "Proponents of psychotropic drugs have long argued that suicide rates ... fell after" such drugs were introduced, though the decline began well before the drugs were widely prescribed.
It is how much important to everyone?

The disease is not treated eloquence, and drugs

It is translated from Italien by the program

The disease is not treated eloquence, and drugs / A. Celsus /

Antidepressant drugs is to facilitate or prevent depression. Prior to the opening of antidepressants to treat depression actively used substances with exciting effects that can cause euphoria of (opium and other opiates, caffeine, ginseng). To reduce anxiety and excitability used valerian, also used the salt bromine. But this coup was the opening in psychopharmacology antidepressants in the early 50's. Since then, for over half a century, these drugs are the key to combating depression. Despite the fact that the era of antidepressants began recently, it already has its "myths of creation."
Since the early 20th century, researchers have experimented with the substance in an attempt to synthesize the drug to ease symptoms of depression, but all the experiments failed. The first antidepressant was "open" in 1957 by accident, when doctors noticed a drug iproniazida, applied for the treatment of tuberculosis. In the main impact of the drugs was and collateral, which was unusual increase sentiment among patients. Soon the drug was used to alleviate symptoms of depression, so much so that as a means of tuberculosis medication itself is not justifiable.
In another version of the drug, opened the Nathan Kline, and its opening was also more than coincidental, he tried using drugs to prove the theory on the location of "ego". During the psychological sessions, Klein said that some patients who gave the injection, suddenly ceased to be concerned about the problems over which they worked. Iproniazid was on the market, but soon proved that it increases the risk of disease jaundice, and the sale of the drug were halted.

At the same time, in Germany, Ronald Kun opened imipromin. Kuhn gave their patients drugs, in order to build on their reactions global classification of mental illness, which German psychiatrists of the time were just obsessed. As in previous cases, the drug was "open" when the patients had improved mood. Unlike iproniazida, imipromin still on the list of official and the WHO to prozaka was the selling antidepressant.
When opened the first antidepressant, no one could have imagined that a few decades antidepressant therapy almost displace other types of depression therapy, but according to a poll conducted in the late 20 th century in the United States, the largest opening of the past century will recognize no theory of relativity , and the Internet, and the little capsule Prozaka.
anti-depressants
anti-depressants 2